Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells
Clinical trial NCT01779050 · TERMINATED
Trial details
- NCT number
- NCT01779050
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-19
- Primary completion
- 2021-09-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.